First Zantac Cancer Risk Trial in California Postponed by Months
The first scheduled trial over claims that GSK's heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed, likely by several months.
Reuters Health Information
source https://www.medscape.com/viewarticle/988802?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/988802?src=rss
Comments
Post a Comment